According to the Company, intravenous administration of the affected product could lead to “site specific infections as well as serious systemic infections which may be life-threatening.” SterRx, LLC ...

Long Grove Pharmaceuticals is set to introduce Sodium Bicarbonate Injection. The product is commonly used in critical care settings yet routinely found on the drug shortages list, the company said.

(RTTNews) - Hospira, Inc., owned by drug major Pfizer Inc., is recalling certain Sodium Bicarbonate and Lidocaine HCl Injections citing the potential for presence of glass particulate matter, the U.S.

CHARLOTTE, N.C.--(BUSINESS WIRE)-- Premier Inc. (NASDAQ: PINC), through its ProvideGx™ program, has partnered with Exela Pharma Sciences, LLC, to supply sodium bicarbonate injection to healthcare ...

Exela Pharma Sciences is recalling an additional 14 lots of Sodium Bicarbonate Injection, USP, 8.4%, 50mEq/50 mL vial, 20-count carton. In total, the Company is recalling 63 lots of the product due to ...

SterRx, LLC today announced the voluntary nationwide recall of three lots of Sodium Bicarbonate in 5% Dextrose Injection 150mEq per 1,000 mL due to waterborne microbial contamination. SterRx, LLC has ...

December 29, 2010 — A voluntary recall has been issued for 39 lots of American Regent's sodium bicarbonate injection because of the presence of particulate matter, the US Food and Drug Administration ...

Hospira, a unit of Pfizer, issued a voluntary recall of sodium bicarbonate and lidocaine HCI injectables due to the possible presence of glass particles in the vials. Monday, Hospira said it recalled ...

Civica Rx and Exela Pharma Sciences are teaming up to manufacture and supply hospitals with sodium bicarbonate injection, which has been in critically short supply. Sodium bicarbonate is a vital ...

Hospira, Inc., a Pfizer company, is voluntarily recalling the lots listed in the table below of 4.2% Sodium Bicarbonate Injection, USP ABBOJECT® Glass Syringe, 5 mEq/10 mL; 8.4% Sodium Bicarbonate ...